Regence BlueShield of Washington prior authorization, page 8

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
L0633Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
L0634Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
L0636Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
L0637Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
L0638Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
L0639Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
L0640Spinal Orthoses: Thoracic-Lumbar-Sacral (TLSO), Lumbar-Sacral (LSO), and LumbarCommercial Pre-authorization List, Pg 1 Original policy
E0766Tumor Treatment Field TherapyCommercial Pre-authorization List, Pg 1 Original policy
81401Genetic Testing for Alzheimer's DiseaseCommercial Pre-authorization List, Pg 1 Original policy
81405Genetic Testing for Alzheimer's DiseaseCommercial Pre-authorization List, Pg 1 Original policy
81406Genetic Testing for Alzheimer's DiseaseCommercial Pre-authorization List, Pg 1 Original policy
81162Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81163Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81164Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81165Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81166Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81167Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81212Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81215Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81216Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81217Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81307Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81308Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81321Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81322Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81323Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81351Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81352Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81404Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81432Genetic Testing for Hereditary Breast, Ovarian, Pancreatic and Prostate Cancer and Li-Fraumeni SyndromeCommercial Pre-authorization List, Pg 1 Original policy
81201Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81202Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81203Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81210Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81288Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81292Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81293Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81294Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81295Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81296Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81297Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81298Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81299Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81300Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81317Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81318Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81319Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81435Genetic Testing for Lynch Syndrome and APC-associated and MUTYH-associated Polyposis SyndromesCommercial Pre-authorization List, Pg 1 Original policy
81225Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and DosingCommercial Pre-authorization List, Pg 1 Original policy
81227Cytochrome p450 and VKORC1 Genotyping for Treatment Selection and DosingCommercial Pre-authorization List, Pg 1 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.